Literature DB >> 23402573

Using common random numbers in health care cost-effectiveness simulation modeling.

Daniel R Murphy1, Robert W Klein, Lee J Smolen, Timothy M Klein, Stephen D Roberts.   

Abstract

OBJECTIVES: To identify the problem of separating statistical noise from treatment effects in health outcomes modeling and analysis. To demonstrate the implementation of one technique, common random numbers (CRNs), and to illustrate the value of CRNs to assess costs and outcomes under uncertainty.
METHODS: A microsimulation model was designed to evaluate osteoporosis treatment, estimating cost and utility measures for patient cohorts at high risk of osteoporosis-related fractures. Incremental cost-effectiveness ratios (ICERs) were estimated using a full implementation of CRNs, a partial implementation of CRNs, and no CRNs. A modification to traditional probabilistic sensitivity analysis (PSA) was used to determine how variance reduction can impact a decision maker's view of treatment efficacy and costs.
RESULTS: The full use of CRNs provided a 93.6 percent reduction in variance compared to simulations not using the technique. The use of partial CRNs provided a 5.6 percent reduction. The PSA results using full CRNs demonstrated a substantially tighter range of cost-benefit outcomes for teriparatide usage than the cost-benefits generated without the technique.
CONCLUSIONS: CRNs provide substantial variance reduction for cost-effectiveness studies. By reducing variability not associated with the treatment being evaluated, CRNs provide a better understanding of treatment effects and risks. © Health Research and Educational Trust.

Entities:  

Keywords:  Variance reduction; common random numbers; cost-effectiveness modeling; osteoporosis

Mesh:

Substances:

Year:  2013        PMID: 23402573      PMCID: PMC3725537          DOI: 10.1111/1475-6773.12044

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  18 in total

1.  Modelling in the economic evaluation of health care: selecting the appropriate approach.

Authors:  Pelham Barton; Stirling Bryan; Suzanne Robinson
Journal:  J Health Serv Res Policy       Date:  2004-04

2.  Is Regret Theory an alternative basis for estimating the value of healthcare interventions?

Authors:  R D Smith
Journal:  Health Policy       Date:  1996-08       Impact factor: 2.980

3.  A taxonomy of model structures for economic evaluation of health technologies.

Authors:  Alan Brennan; Stephen E Chick; Ruth Davies
Journal:  Health Econ       Date:  2006-12       Impact factor: 3.046

4.  Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques.

Authors:  Steven M Shechter; Andrew J Schaefer; R Scott Braithwaite; Mark S Roberts
Journal:  Med Decis Making       Date:  2006 Sep-Oct       Impact factor: 2.583

5.  The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis.

Authors:  Harry K Genant; Johan Halse; Walter G Briney; Li Xie; Emmett V Glass; John H Krege
Journal:  Curr Med Res Opin       Date:  2005-07       Impact factor: 2.580

6.  Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment.

Authors:  Richard Prince; Adrien Sipos; Anwar Hossain; Unni Syversen; Sophia Ish-Shalom; Ewa Marcinowska; Johan Halse; Robert Lindsay; Gail P Dalsky; Bruce H Mitlak
Journal:  J Bone Miner Res       Date:  2005-05-02       Impact factor: 6.741

Review 7.  Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

Authors:  J A Kanis; M Stevenson; E V McCloskey; S Davis; M Lloyd-Jones
Journal:  Health Technol Assess       Date:  2007-03       Impact factor: 4.014

8.  Keeping the noise down: common random numbers for disease simulation modeling.

Authors:  Natasha K Stout; Sue J Goldie
Journal:  Health Care Manag Sci       Date:  2008-12

9.  Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.

Authors:  Robert Lindsay; Wim H Scheele; Robert Neer; Gerhardt Pohl; Silvano Adami; Carlos Mautalen; Jean-Yves Reginster; Jan J Stepan; Stephen L Myers; Bruce H Mitlak
Journal:  Arch Intern Med       Date:  2004-10-11

10.  Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.

Authors:  J Lundkvist; O Johnell; C Cooper; D Sykes
Journal:  Osteoporos Int       Date:  2005-07-19       Impact factor: 4.507

View more
  3 in total

1.  Economic evaluations with agent-based modelling: an introduction.

Authors:  Jagpreet Chhatwal; Tianhua He
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

2.  Introduction to Metamodeling for Reducing Computational Burden of Advanced Analyses with Health Economic Models: A Structured Overview of Metamodeling Methods in a 6-Step Application Process.

Authors:  Koen Degeling; Maarten J IJzerman; Mariel S Lavieri; Mark Strong; Hendrik Koffijberg
Journal:  Med Decis Making       Date:  2020-04       Impact factor: 2.583

3.  Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data.

Authors:  Michael Willis; Christian Asseburg; April Slee; Andreas Nilsson; Cheryl Neslusan
Journal:  Diabetes Ther       Date:  2020-09-15       Impact factor: 2.945

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.